Grants and Contributions:
Title:
ICU Ventilation Add-on Device
Agreement Number:
975391
Agreement Value:
$465,526.00
Agreement Date:
Jul 12, 2021 - Sep 30, 2023
Description:
Recognizing trends toward volatile anaesthetic use in ICU, DMF’s core memsorb™ technology will be used to develop a modular add-on device for existing ICU ventilators to enhance clinical outcomes and improve environmental footprint in perioperative ICU volatile sedation.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Dartmouth, Nova Scotia, CA B2Y 4M9
Reference Number:
172-2021-2022-Q2-975391
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
809537517
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 214 days. The total amended value is 141,793 dollars.
Amendment Date
Oct 3, 2022
Recipient's Legal Name:
DMF Medical Incorporated
Federal Riding Name:
Dartmouth--Cole Harbour
Federal Riding Number:
12004
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: